Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1833141 · FYE Mar 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $7.60Day −1.30%Mkt cap $164MOff 52W high −11.1%Vol (1Y) 94.5%
Daily closing price, split-adjusted to the current basis; 0.5y shown of 130 bars on file. Sampled to 130 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.1% of sh out |
| Days to cover2.9d |
| 13F net flow (QoQ)−21.75% |
| Top-10 13F concentration77.9% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-CAD 113.1M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CAD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
No return windows available for HELP.
| Ann. volatility (1Y)94.5% |
| Ann. volatility (3Y)94.5% |
| Sharpe (1Y)0.54 |
| Sharpe (3Y)0.54 |
| Max drawdown (1Y)−54.6% |
| Max drawdown (3Y)−54.6% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Venrock Adviser, LLC | 3.9M | $18M | 17.83% | +0.3% |
| ORBIMED ADVISORS LLC | 3.8M | $18M | 17.74% | −0.2% |
| MILLENNIUM MANAGEMENT LLC | 2.4M | $12M | 11.18% | +134.9% |
| ACORN CAPITAL ADVISORS, LLC | 1.5M | $7M | 7.13% | −2.1% |
| Rosalind Advisors, Inc. | 1.5M | $7M | 7.09% | −7.6% |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.4M | $7M | 6.53% | +12.2% |
| Deep Track Capital, LP | 1.3M | $6M | 6.08% | −29.2% |
| MORGAN STANLEY | 1.0M | $5M | 4.75% | −21.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 111.6% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 2,537,135 shares (settlement 2026-04-30) accounts for the excess.
No reported quarters on file for HELP.
